Mammoth Biosciences

@mammothbiosci

We harness nature’s diversity to power the next gen of CRISPR products. Using novel CRISPR systems, we’re creating a platform to read & write the code of life.

Vrijeme pridruživanja: rujan 2017.

Tweetovi

Blokirali ste korisnika/cu @mammothbiosci

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @mammothbiosci

  1. Prikvačeni tweet
    30. sij

    Proud to announce our $45M Series B to expand our platform into therapeutics & broaden access to our IP to develop clinical applications w/ unprecedented speed/accuracy. Thanks to & all our investors. Read more via :

    Prikaži ovu nit
    Poništi
  2. proslijedio/la je Tweet
    31. sij

    portfolio company announces $45M in new funding. We are incredibly proud to have supported this team and their mission since the seed round. Their work is more important than ever. cc:

    Poništi
  3. 31. sij
    Poništi
  4. proslijedio/la je Tweet
    31. sij

    " is partnering with UCSF researchers on a diagnostic, a partnership that couldn’t have come too soon," writes

    Poništi
  5. proslijedio/la je Tweet
    31. sij

    31January: How is addressing the outbreak? And how does it plan to spend the $45M in new financing it received? My latest for :

    Poništi
  6. 31. sij

    Hot on the tail of our successful Series B announcement, we’ve opened up many new positions at Mammoth! Visit to find openings for Research Associates, Scientists, Product Development roles, & a Director of .

    Poništi
  7. proslijedio/la je Tweet
    31. sij

    Huge congrats to , , , Jennifer Doudna, and the whole Team on great progress building the platform for CRISPR Dx & Tx, and Min Cui/ Decheng, , and on Series B funding! I'm honored to join the Board.

    Poništi
  8. proslijedio/la je Tweet
    31. sij

    This group will change the world for the better...congrats on the $45M Series B and the team!

    Poništi
  9. proslijedio/la je Tweet
    30. sij

    Mammoth Biosciences aims to be Illumina for the gene editing generation by

    Poništi
  10. proslijedio/la je Tweet
    30. sij

    Excited to announce our oversubscribed $45M Series B to advance 's next-generation CRISPR Platform into both diagnostic and therapeutic products! A testament to the great team we're building at Mammoth and an exciting start to a busy year.

    Poništi
  11. proslijedio/la je Tweet
    30. sij

    Amazing to see how far has come since the Seed round. CRISPR as a platform has enormous potential to tackle global health challenges across both Dx and Tx. Honored to be part of your journey and Prof. Doudna

    Poništi
  12. 30. sij

    Be sure to check out our feed to learn about all the amazing happenings at Mammoth. From funding announcements to corona virus diagnostics. Importantly, you can be a part of all the excitement! Find info on our many open positions here:

    Poništi
  13. proslijedio/la je Tweet
    30. sij

    . is working with to develop a quicker diagnostic test to stop the spread of the disease:

    Poništi
  14. proslijedio/la je Tweet
    30. sij

    Mammoth Biosciences, a company founded by members that uses gene-editing technology Crispr for disease testing, raised $45 million—and its tech is already being used against coronavirus

    Poništi
  15. proslijedio/la je Tweet
    30. sij

    Doudna-founded CRISPR upstart bags $45M for new Cas family, extends its reach into therapeutics

    Poništi
  16. proslijedio/la je Tweet
    30. sij
    Poništi
  17. proslijedio/la je Tweet
    30. sij

    Thanks to our fantastic investors and the world-class Mammoth team, it's an honor to have such an amazing group working towards our mission! Apply to join us !

    Poništi
  18. proslijedio/la je Tweet
    30. sij

    Excited to announce our Series B raise! Thanks to the entire team at for making this possible. We look forward to advancing our CRISPR platform to enable next-gen diagnostics and gene editing tools. Come join us in the CRISPR revolution!

    Poništi
  19. proslijedio/la je Tweet
    30. sij

    Gene editing company Mammoth plans to leverage its IP position and $45M B round to expand from diagnostics to therapeutics

    Poništi
  20. 30. sij

    One of the many things we're doing with this funding - hiring! Check out openings ranging from Research Associates & Scientists to Project Manager & Director of here:

    Prikaži ovu nit
    Poništi
  21. proslijedio/la je Tweet
    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·